Special Report: The 2024 Lab Enforcement Landscape
Lab leaders should be wary of telemedicine arrangements, certain marketing firms, and unnecessary PGx and CGx testing
Lab leaders should be wary of telemedicine arrangements, certain marketing firms, and unnecessary PGx and CGx testing
From - G2 Compliance Advisor
Amidst the guilty pleas and sentencing of dozens of individuals, the laboratory company Biodiagnostic Laboratory Services LLC (BLS) entered a…
From - G2 Compliance Advisor
Nearly a year to the day after another nationwide Strike Force takedown, the Department of Justice announced last week what it says is a…
From - G2 Compliance Advisor
A common message emerging from the government enforcement agencies is that data analytics have been critical to fraud and…
From - G2 Compliance Advisor
The U.S. Department of Health and Human Services' Office of Inspector General (OIG) touted its efforts and achievements for the six-month period ending…